Apollomics, Inc. (APLM)
USD 7.89
(5.91%)
USD 7.89
(5.91%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -43.2 Million | -42.82 Million | -43.31 Million | -35.68 Million | -21.94 Million |
| Net Income | -172.59 Million | -240.81 Million | -94.79 Million | -74.9 Million | -45.9 Million |
| Depreciation & Amortization | 669 Thousand | 775 Thousand | 681 Thousand | 609 Thousand | 369 Thousand |
| Deferred income taxes | 76.36 Million | 396 Thousand | 40.42 Million | 27.52 Million | - |
| Stock-based compensation | 12.68 Million | 3.58 Million | 8.12 Million | 4.51 Million | - |
| Change in working capital | -3.56 Million | 6.48 Million | 2.64 Million | 3.06 Million | 1.11 Million |
| Other non-cash items | 43.22 Million | 186.74 Million | -384 Thousand | 3.52 Million | 23.22 Million |
| Investing Cash Flow | 21.36 Million | 29.05 Million | -38.95 Million | 2.32 Million | -29.86 Million |
| Investments in PPE | -6000.00 | -367 Thousand | -7.55 Million | -10.14 Million | -857 Thousand |
| Acquisitions | 58 Thousand | - | -7.03 Million | -9.67 Million | - |
| Investment purchases | - | - | -103.79 Million | -6 Million | -89.4 Million |
| Sales/Maturities of investments | 20.48 Million | 29 Million | 71.94 Million | 18 Million | 60.4 Million |
| Other Investing Activities | 884 Thousand | 420 Thousand | 7.47 Million | 10.13 Million | -5000.00 |
| Financing Cash Flow | 21.22 Million | -294 Thousand | -1.64 Million | 125.51 Million | 9.51 Million |
| Debt repayment | -444 Thousand | -593 Thousand | -528 Thousand | -472 Thousand | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 17.55 Million | 392 Thousand | 141 Thousand | 6.02 Million | 9.82 Million |
| Other Financing Activities | -2.77 Million | -93 Thousand | -1.25 Million | 119.95 Million | - |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other working capital | -932 Thousand | 6.48 Million | 2.64 Million | 3.06 Million | 1.11 Million |
| Cash at beginning of period | 32.67 Million | 46.74 Million | 130.64 Million | 38.48 Million | 80.78 Million |
| Cash at end of period | 32.05 Million | 32.67 Million | 46.74 Million | 130.64 Million | 38.48 Million |
| Capital Expenditure | -6000.00 | -367 Thousand | -7.55 Million | -10.14 Million | -857 Thousand |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -619 Thousand | -14.06 Million | -83.9 Million | 92.15 Million | -42.29 Million |
| Free Cash Flow | -43.21 Million | -43.19 Million | -50.86 Million | -45.82 Million | -22.8 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -17.6 Million | -17.6 Million | -10.95 Million | -172.59 Million | -10.95 Million | -75.34 Million |
| Depreciation & Amortization | 99.5 Thousand | 99.5 Thousand | 156 Thousand | 669 Thousand | 156 Thousand | 178.5 Thousand |
| Deferred income taxes | - | - | - | 76.36 Million | - | - |
| Stock-based compensation | - | - | 3.7 Million | 12.68 Million | 3.7 Million | 2.64 Million |
| Change in working capital | 472 Thousand | 472 Thousand | 951.5 Thousand | -3.56 Million | 951.5 Thousand | -1.41 Million |
| Other non-cash items | 9.03 Million | 9.03 Million | -3.26 Million | 43.22 Million | -3.26 Million | 61.74 Million |
| Investing Cash Flow | 2.87 Million | 2.87 Million | 10.8 Million | 21.36 Million | 10.8 Million | -121 Thousand |
| Investments in PPE | -12 Thousand | -12 Thousand | - | -6000.00 | - | -3000.00 |
| Acquisitions | - | - | - | 58 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | 20.48 Million | - | - |
| Other Investing Activities | 2.88 Million | 2.88 Million | 10.8 Million | 884 Thousand | 10.8 Million | -118 Thousand |
| Financing Cash Flow | 2.06 Million | 2.06 Million | 1.99 Million | 21.22 Million | 1.99 Million | 8.62 Million |
| Debt repayment | - | - | - | -444 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 17.55 Million | - | - |
| Other Financing Activities | 2.06 Million | 2.06 Million | 1.99 Million | -2.77 Million | 1.99 Million | 8.62 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 472 Thousand | 472 Thousand | 951.5 Thousand | -932 Thousand | 951.5 Thousand | -1.41 Million |
| Cash at beginning of period | - | - | - | 32.67 Million | - | - |
| Cash at end of period | -3.06 Million | -3.06 Million | 3.38 Million | 32.05 Million | 3.38 Million | -3.68 Million |
| Capital Expenditure | -12 Thousand | -12 Thousand | - | -6000.00 | - | -3000.00 |
| Effect of forex changes on cash | -3000.00 | -3000.00 | -9500.00 | - | -9500.00 | 9500.00 |
| Net cash flow / Change in cash | -3.06 Million | -3.06 Million | 3.38 Million | -619 Thousand | 3.38 Million | -3.68 Million |
| Free Cash Flow | -8 Million | -8 Million | -9.4 Million | -43.21 Million | -9.4 Million | -12.2 Million |
IDWM
PTXLF
603320
MEGACPO
ALVET
PCIB